Giant Biogene Holding Co. Ltd. logo

Giant Biogene Holding Co. Ltd. (2367)

Market Closed
11 Aug, 08:00
HKEX HKEX
29. 72
HKD
+0.3
+1.0197%
HKD
51.2B Market Cap
- P/E Ratio
1.96% Div Yield
3.23M Volume
- Eps
29.42 HKD
Previous Close
Add Transaction
Day Range
29.3 30.48
Year Range
24.2 65.7
Want to track 2367 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

2367 closed today higher at 29.72 HKD, an increase of 1.0197% from yesterday's close, completing a monthly increase of 12.1509% or 3.22 HKD. Over the past 12 months, 2367 stock lost -10.6971%.
2367 pays dividends to its shareholders, with the most recent payment made on Jun 25, 2026. The next estimated payment will be in 1 month ago on Jun 25, 2026 for a total of 1.3894 HKD.
The last earnings report, released on Mar 19, 2026, missed the consensus estimates by -0.768%. On average, the company has fell short of earnings expectations by -0.384%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

2367 Chart

People also search for

WH Group Limited
8.16 HKD
+1.3035%
China Resources Mixc Lifestyle Services Ltd.
39.82 HKD
-0.8466%
Budweiser Brewing Company APAC Limited
6.41 HKD
-0.9281%
Eastroc Beverage (Group) Co., Ltd.
118.5 HKD
-5.427%
China Resources Beer
22.16 HKD
-1.6859%

Giant Biogene Holding Co. Ltd. (2367) FAQ

What is the stock price today?

The current price is 29.72 HKD.

On which exchange is it traded?

Giant Biogene Holding Co. Ltd. is listed on HKEX.

What is its stock symbol?

The ticker symbol is 2367.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.96%.

What is its market cap?

As of today, the market cap is 51.2B.

Has Giant Biogene Holding Co. Ltd. ever had a stock split?

No, there has never been a stock split.

Giant Biogene Holding Co. Ltd. Profile

Household Products Industry
Consumer Staples Sector
Mr. Jianya Yan CEO
HKEX Exchange
KYG3887G1091 ISIN
China Country
1,512 Employees
1 Jun 2026 Last Dividend
- Last Split
- IPO Date

Overview

Giant Biogene Holding Co., Ltd., founded in 2000 and headquartered in Xi'an, the People's Republic of China, operates as an investment holding company with a robust focus on the research, development, manufacture, and sale of bioactive material-based beauty and health products. Primarily serving the domestic market in China, the company has carved a niche for itself in the life sciences sector by prioritizing innovative technologies, especially in the creation of rare ginsenosides technology-based functional foods, alongside producing medical devices. Their dedication to blending science with wellness solutions has positioned them as a leader in the rapidly evolving biotechnology and health products industry.

Products and Services

Giant Biogene Holding Co., Ltd. offers a wide range of products focused on enhancing consumers' health and beauty needs. Their offerings embody the intersection of cutting-edge biotechnology and practical wellness solutions, providing both therapeutic and preventive benefits.

  • Functional Skincare Products - Under the brands Comfy and Collgene, Giant Biogene delivers a line of skincare products synthesized from bioactive materials. These products are designed to nourish, protect, and rejuvenate the skin, addressing various skin conditions and promoting overall skin health.
  • Medical Dressings - Leveraging advanced biotechnologies, the company manufactures medical dressings that facilitate wound healing and provide effective solutions for wound care. These products underscore Giant Biogene's commitment to combining medical research with practical applications in healthcare.
  • Rare Ginsenosides Technology-Based Functional Foods - A standout in their product lineup, this range demonstrates the company’s pioneering work in utilizing rare ginsenosides extracted from ginseng. The functional foods developed from this technology aim to enhance physical health and wellness through natural, scientifically-backed means.
  • Medical Devices - Giant Biogene also diversifies its portfolio by offering medical devices. These products are built on the foundation of rigorous research and development efforts, intended to meet the growing demands of the healthcare industry for reliable, innovative medical solutions.

Contact Information

Address: No. 1855, Shanglin Yuan
Phone: 86 29 8115 6502